Webinar | Is Your Packaging PPWR Ready? Register Here

US Patent Damages Hit $4.19B, Verizon and Amazon Among the Top Payers

Authors

Digital Marketing Associate
Group Manager

Patent disputes in the U.S. can turn into a billion-dollar courtroom showdown. Companies fight hard to protect their patents, and the payouts are massive when they win. In 2024, 72 patent infringement lawsuits reached a jury verdict. General Access Solutions received the largest award—$857 million in infringement damages. The year saw 37 cases cross the $10 million mark, 17 exceed $50 million, and 12 surpass $100 million in damages.

This analysis covers major patent infringement jury verdicts, key litigation hotspots, and the most litigated industries. See which rulings set new legal precedents and whether your products might face infringement challenges.

Download the report to explore major cases of 2024, track enforcement trends, and check their impact on your patents.

Top 10 patent infringement damages verdicts, and how much did the jury award?

SR. NoCaseIndustryCase Verdict Date DateCase StatusPatentsTotal Amount
1General Access Solutions, Ltd. v. Cellco Partnership d/b/a Verizon Wireless et alTelecommunications (5G)June 28, 2024TerminatedUS7230931B2 | US9426794B2$847.00 million
2Kove IO, Inc. v. Amazon Web Services, Inc.Cloud ComputingApril 10, 2024TerminatedUS7103640B1 | US7233978B2 | US7814180B2$525.00 million
3Netlist, Inc. v. Micron Technology Texas, LLC et alSemiconductor (Memory)May 23, 2024TerminatedUS11093417B2 | US7619912B2 | US9858215B1$425.00 million
4SPEX Technologies, Inc. v. Western Digital Corporation et alSecurityOctober 18, 2024TerminatedUS6003135A | US6088802A$315.72 million
5MR Technologies, GMBH v. Western Digital Technologies, Inc.Hard Disk Drive (HDD)July 26, 2024TerminatedUS11138997B2 | US9928864B2$262.39 million
6IPA Technologies Inc. v. Microsoft CorporationAI assistantMay 10, 2024TerminatedUS7069560B1$242.00 million
7Mojo Mobility Inc v. Samsung Electronics Co., LTD, et alWireless chargingSeptember 13, 2024ActiveUS11201500B2 | US11316371B1 | US11342777B2 | US11462942B2 | US9577440B2$192.14 million
8AlmondNet, Inc. et al v. Amazon.com, Inc. et alOnline AdvertisingJune 14, 2024TerminatedUS7822639B2 | US8671139B2$121.95 million
9Netlist, Inc. v. Samsung Electronics Co., Ltd. et alSemiconductor (Memory)November 22, 2024TerminatedUS10268608B2 | US1093417A | US7619912B2$118.00 million
10Nippon Shinyaku., Ltd. v. Sarepta Therapeutics, Inc.Pharmaceutical compositionDecember 20, 2024ActiveUS10385092B2 | US994851A$115.22 million

Key insights from patent infringement lawsuits in 2024

The estimated total damages paid were $4.19 billion. Most cases dealt with AI, cloud computing, semiconductors, and software patents.

Companies involved in most litigations:

  • Samsung Electronics faced multiple high-profile patent infringement lawsuits, especially in semiconductors and mobile technology. 
  • Amazon, Microsoft, and IBM were involved in several cloud computing and AI-related legal battles.
  • Apple and Nokia were frequent defendants in consumer electronics and communications disputes.

Companies that paid the most in damages:

  • Samsung Electronics Co., Ltd. – One of the biggest infringement damages payers in 2024, facing multiple costly settlements.
  • Amazon Web Services (AWS) – Paid significant damages in cloud storage and AI-related patent lawsuits.
  • Micron Technology & Netlist – Faced major financial losses in semiconductor and memory chip patent cases.
  • Biopharma Companies (AstraZeneca, Sarepta, Jazz Pharmaceuticals) – Incurred high costs due to drug formulation and biologics-related disputes.

Legal hotspots:

Eastern District of Texas (EDTX) – The most active court for patent disputes.
District of Delaware (DDE) – Hosted many technology-related lawsuits.
Western District of Texas (WDTX) – Increasingly popular for tech patent cases.

Conclusion

GreyB’s analysis of the 72 patent infringement jury verdicts in 2024 saw semiconductor and AI patents as part of most disputes.  

Since January 2019, organizations have published over 480,000 AI patent applications. This includes applications from major patent offices like EPO, USPTO, CN, KR, and JP. China is leading this growth with a 300% jump in patent filings from 2019 to 2022. In one year alone, applications topped 70,000.

Tracking competitor patents is no longer enough. As AI integrates into biotech, automotive, and telecommunications, enforcement risks have shifted. The real challenge?

Predicting where the next wave of patent lawsuits will hit.

The best Freedom-to-Operate (FTO) strategies go beyond patent searches. By integrating:

  • Patent litigation trends (who is enforcing, where, and how aggressive they are)
  • Competitor filing behaviors (which markets they are protecting).
  • Industry-specific risk assessments (where infringement challenges are rising).
  • Studying the patent litigation trends

Get a detailed risk map for product launches to avoid expensive legal disputes. Fill out the form today to see where patent enforcement is surging and how to stay ahead of them.

hbspt.forms.create({ region: “na1”, portalId: “1791848”, formId: “03d7a1b1-db99-4943-82b5-57c3706c9e1b” });

Authored by: Annie Sharma and Rohit Sood

Share This Article:

Authors

Digital Marketing Associate
Group Manager

Related Articles

Table of Contents

More Insights For You

Titanium Dioxide Alternatives in Pharmaceuticals

The European Commission has recently postponed the ban on TiO2 in medicinal products due to the lack of viable alternatives. This move highlights the overreliance on TiO2 and the need

FDA DRUG APPROVALS 2025

In 2025, the FDA has approved 28 new therapies, each signaling how the next decade of pharma innovation and IP strategy will unfold. From oncology and rare diseases to quality-of-life

Europe exclusivity expiration

In 2025, 98 drugs across Europe will lose market exclusivity, opening multi-billion-euro opportunities for generic and biosimilar manufacturers. These expirations span oncology, immunology, neurology, infectious diseases, and veterinary medicine, setting

novartis

When a single patent attracts 17 separate oppositions at the European Patent Office, it signals more than just legal friction. In the pharmaceutical market, this could signal a billion-dollar market

This Ozempic Patent Lapse In Canada Opens Door For Generic Competition By 2026 (1)

Novo Nordisk’s Canadian Patent CA 2601784 (Acylated GLP-1 Compounds), protecting Ozempic and Wegovy’s active ingredient, semaglutide, has lapsed. This event, linked to the non-payment of a maintenance fee, has drawn

AI in Drug Discovery

If there’s an industry that needs AI to serve as an inflection point in its trajectory, it is drug development. Long before OpenAI opened the floodgates of the AI push,

Baiya PhytoPharm scouted interview

Conventional cell culture methods are costly and inefficient, creating barriers to developing life-saving medications. Baiya PhytoPharm addresses these challenges by transforming plants into living “pharmaceutical factories.“ By genetically modifying plants

FluIDect Scouted Interview

Current pathogen testing methods can take up to 7 days to yield results. This delay leads to production halts in the food and pharma industries with strict quality control requirements.

Red Dye 3 Alternatives

The U.S. FDA banned Red Dye No. 3 in foods, dietary supplements, and oral medicines. The dye’s links to potential health risks have fueled public demand for cleaner, additive-free products.

Facing A Roadblock On Your Project?

Our Experts Are Here To Help.